Epstein Secrets

ees. The New York Times <https://www.nytimes.com/2020/11/12/business/pfizer-covid-vaccine-coronavirus.html> (11/12, Gelles, Robins, 18.61M) reports Pfizer, the US government, and "the public health community face a new challenge: quickly making millions of doses of the vaccine and getting them to the h

re are rumors the president may be cleaning house at LISA, with one high-level official reportedly asked to resign already. This is dangerous." Sen. Angus King (I-ME), co- chair of the US Cyberspace Solarium Commission, "called Krebs' work with states on election security 'amazing' in a recent press briefin

dena "expects to have an announcement on the vaccine's efficacy by the end of the month, the company said in a statement Wednesday." Both Modena and Pfizer "use messenger RNA for their vaccines," and NIAID Director Fauci "has said Pfizer's promising outcomes are good news for Moderna, too." Politico <h

ies are "lining up on Capitol Hill to push such a proposal while the incoming administration zeroes in on addressing cybersecurity challenges." Sen. Angus King (I-ME) said, "I think the coordination needs to be improved, and the way to do that is to have somebody at the center whose job it is to provide th

an Orlando Hernandez and Bolivia's then-interim President Jeanine Anez. All have recovered." Mexico's Vaccination Program Stalls Due To Delays from Pfizer. The Los Angeles Times (1/24, Linthicum, 3.37M) reports that hospitals in many states in Mexico "are near EFTA00148194 capacity, ventilators and

n has a chance of getting the kind of support it would need to pass Congress with bipartisan backing." The AP (1/24, Madhani, Mascaro) reports Sen. Angus King (I-ME) said the talks were a "serious effort." King said, "There was not a hint of cynicism or lack of commitment to at least trying to work someth

been working beyond the drugmakers' initial experiments." The Minneapolis Star Tribune (3/29, Olson, 855K) says "clinical trials of the Moderna and Pfizer vaccines only looked at prevention of symptomatic infections, so the latest study of their effectiveness in health care and emergency medical worke

luded in the 2021 National Defense Authorization Act to increase coordination of the nation's defense against cyberattacks and cyberespionage." Sen. Angus King (I-ME), who was co-chairman of the Cyberspace Solarium Commission, "has expressed concern that the cyber director position has remained vacant mont

istribution Requires Cooperation Between Governments, Drug Makers, Suppliers, Employees. The New York Times (11/12, Gelles, Robins, 18.61M) reports Pfizer, the US government, and "the public health community face a new challenge: quickly making millions of doses of the vaccine and getting them to the h

e are rumors the president may be cleaning house at CISA, with one high-level official reportedly asked to resign already. This is dangerous." Sen. Angus King (I-ME), co-chair of the US Cyberspace Solarium Commission, "called Krebs' work with states on election security `amazing' in a recent press briefing

na "expects to have an announcement on the vaccine's efficacy by the end of the month, the company said in a statement Wednesday." Both Moderna and Pfizer "use messenger RNA for their vaccines," and NIAID Director Fauci "has said Pfizer's promising outcomes are good news for Moderna, too." Politico (1

ies are "lining up on Capitol Hill to push such a proposal while the incoming administration zeroes in on addressing cybersecurity challenges." Sen. Angus King (I-ME) said, "I think the coordination needs to be improved, and the way to do that is to have somebody at the center whose job it is to provide th

d Monday." Defense Secretary Austin "said in a memo to the staff Monday that he would seek to speed up a vaccine mandate if the F.D.A. approved the Pfizer-BioNTech vaccine before the middle of September, which the agency aims to do." The Wall Street Journal (8/9, Al, Siddiqui, Subscription Publication,

c and social- policy package." The "so-called 'real corporate profits tax' was a key part of her presidential campaign, and she has enlisted Senator Angus King, the Maine independent, to help press her case that profitable companies should be taxed, regardless of loopholes and maneuvers that have allowed m

na "expects to have an announcement on the vaccine's efficacy by the end of the month, the company said in a statement Wednesday." Both Moderna and Pfizer "use messenger RNA for their vaccines," and NIAID Director Fauci "has said Pfizer's promising outcomes are good news for Moderna, too." Politico (1

ies are "lining up on Capitol Hill to push such a proposal while the incoming administration zeroes in on addressing cybersecurity challenges." Sen. Angus King (I-ME) said, "I think the coordination needs to be improved, and the way to do that is to have somebody at the center whose job it is to provide th

istribution Requires Cooperation Between Governments, Drug Makers, Suppliers, Employees. The New York Times (11/12, Gelles, Robins, 18.61M) reports Pfizer, the US government, and "the public health community face a new challenge: quickly making millions of doses of the vaccine and getting them to the h

e are rumors the president may be cleaning house at CISA, with one high-level official reportedly asked to resign already. This is dangerous." Sen. Angus King (I-ME), co-chair of the US Cyberspace Solarium Commission, "called Krebs' work with states on election security `amazing' in a recent press briefing